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Mohammad Ali* and David A SackAbstract
Recently, the World Health Organization (WHO) declared that the spread of polio is an international public health
emergency, and a coordinated international response is sought. Although the importance of such a response is
recognized, there are challenges to stopping the spread of polio and achieving a polio free world. The most important
issue is directing limited national resources to the specific areas where polio is endemic. In an article published in BMC
Medicine, Upfill-Brown and his colleagues recognized this problem and successfully identified the potential risk areas in
Nigeria using a validated spatial predictive model of wild poliovirus circulation. They also showed that a lower
vaccine-derived population immunity is associated with the probability of a higher number of wild poliovirus cases within
a district. Identification of the potential risk areas and understanding the magnitude of risk may help direct limited resources
of the endemic countries to areas most at risk to maximize the impact of interventions and motivate the people to
participate in the intervention program. These efforts are crucial if these endemic countries hope to eradicate polio.
Please see related research article: http://www.biomedcentral.com/1741-7015/12/92.
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Polio was first traced as a disease of a separate clinical entity
by Michael Underwood in 1789 [1]. The disease mainly af-
fects children under five years old. Three types of poliovirus,
designated as 1, 2 and 3, may cause polio [2], although only
type 1 appears to be circulating currently. Type 2 was last
reported in 1999 and type 3 was last reported in 2012.
Humans are the only reservoir of poliovirus [3]. The virus
is transmitted person-to-person through fecal-oral and
oral-oral routes, or less frequently by water and milk [4,5].
It multiplies in the intestine and spreads to the central ner-
vous system, causing paralysis in 1 in every 200 infections
[6], with a case fatality of 5% to 10% [7]. Polio became a
major public health issue in late Victorian times when
major epidemics occurred in the United States and Europe.
Significant progress toward polio eradication has been
achieved during 2012/2013 and, as a result, 80% of the
world’s population now live in WHO regions certified as
polio-free [8]. However, the poliovirus remains endemic
in three countries: Pakistan, Afghanistan and Nigeria.
During 2014, as of May 20, wild poliovirus 1 has already
spread to central Asia, the Middle East (Syria to Iraq) and* Correspondence: mali25@jhu.edu
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Attacks on vaccination workers in Pakistan are thought to
have allowed the virus to spread across borders. Infections
in Pakistan, Cameroon and Syria increase the risk for fur-
ther wild poliovirus exportations in 2014. Accordingly,
WHO declared the spread of polio to be an international
public health emergency [9]. This is only the second time
in the WHO's history that it has made such a declaration,
the first being during the swine flu pandemic of 2009. The
WHO also listed Afghanistan, Equatorial Guinea, Ethiopia,
Iraq, Israel, Somalia and Nigeria as posing an ongoing risk
for new wild poliovirus exportations in 2014.
Although the importance of a coordinated internatio-
nal response is recognized, there are challenges to stop-
ping the spread of polio and achieving a polio-free world.
One important issue is how to direct the limited resources
within the polio endemic countries. Although all children
need to receive vaccine, decisions are still needed to know
where special efforts are required. To assist with these
decisions, Upfill-Brown and colleagues identified the
potential risk areas in Nigeria using a spatial modelling
technique and the Nigerian Acute Flaccid Paralysis sur-
veillance database maintained by the Nigerian WHO [10].
Their results showed that lower vaccine-derived popu-
lation immunity is associated with the probability of aLtd. This is an Open Access article distributed under the terms of the Creative
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Based on the results of their spatial model, they also esti-
mated that under-five oral polio vaccine (OPV)-induced
population immunity would decrease by 8% to 9% in a six
month period in the absence of any vaccination. Although
a substantial amount of residual spatial variation remains
in their model due to the paucity of the data on poverty,
malnutrition, sanitation and level of health services, all of
which influence wild polio virus transmission potential
and population vaccine efficacy [11], the predictive accur-
acy of their model was found to be very high (more than
85%). Such model results are useful for political and reli-
gious advocacy as well as public health policy makers to
allocate resources to the highest risk areas.The challenges to eradicating polio from the globe
The global program’s focus is on stopping polio trans-
mission in the remaining three endemic countries. Trans-
mission of wild poliovirus has never been eliminated
in Nigeria, and neighboring countries have become re-
infected by strains originating from Nigeria [12]. Presently,
Nigeria accounts for almost 60% of world’s polio cases;
thus, this country is considered to be the biggest threat to
a polio-free world [13]. Besides Nigeria, wild poliovi-
ruses continue to persist in Pakistan and one part of
Afghanistan. Eight other countries are currently respond-
ing to outbreaks related to imported viruses [14]. To stop
the transmission of poliovirus, every child in the three en-
demic countries needs to be immunized, but security risks
limit access in some of the endemic areas of Afghanistan
and Pakistan. By inhibiting vaccination programs, these
security risks pose a continuing threat to achieving a
polio-free world. However, as mentioned by Upfill-Brown
et al., the impact of the vaccination efforts will be maxi-
mized if one can efficiently direct limited resources and
specially trained personnel, along with community out-
reach activities and satellite vaccinator tracking to the
most at-risk areas. A validated predictive model of wild
poliovirus circulation would, therefore, greatly inform
prioritization efforts by accurately forecasting areas at
greatest risk, thus enabling the greatest effect of the
program.
The threat of the spread of polio between countries, es-
pecially between these endemic countries and their neigh-
bors's risks the health and wellbeing of the countries of
the region and also increases the costs of its containment
because of the need for supplementary immunization
campaigns. However, just as polio spreads between coun-
tries, it also spreads within these endemic countries and
immunizing these areas which are the source of the spread
should reduce the overall disease burden within these en-
demic countries and should facilitate the elimination of
the virus in these endemic countries.While vaccination is crucial, it must also be realized
that OPV is less effective in children in many developing
countries. The reasons for the lower effectiveness of an
oral vaccine are not known, but some potential factors
may include tropical enteropathy, malnutrition, interfe-
rence from maternal breast milk or serum antibodies, al-
terations in the gut microbiota, and genetic susceptibility
[15]. Other reasons could include (in some cases) lack of a
cold chain resulting in damage to the live virus vaccine;
interference by infection with endogenous enteroviruses
[16]; or interference via co-administration of OPV and
rotavirus vaccines [17].
Conclusions
It is important that Nigeria become polio free to establish
a polio-free Africa. Similarly, Pakistan and Afghanistan
need to be polio free to establish a polio-free Asia. The
predictive model of UpFill-Brown et al. demonstrated a
clear link between vaccination coverage and the magni-
tude of the risk of poliomyelitis in Nigeria.
The funding constraints as well as the logistic chal-
lenges of OPV campaigns are huge. One must attempt
to reach more than 90% of young children through mass
OPV immunization campaigns in countries with reestab-
lished transmission; this task is similar in scale to those
tasks in the remaining endemic countries where conflict,
insecurity and weak public services complicate eradica-
tion operations [14,18]. These issues need to be success-
fully addressed to achieve a polio free world.
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